Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ASND

Recent news which mentions ASND

< Previous 1 2 3 4 5 Next >
$100 Invested In This Stock 10 Years Ago Would Be Worth $6,500 Today
Tickers ASND NEWS
Tags Trading Ideas ASND Benzinga
From Benzinga
FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
Tickers ASND NEWS
Tags Market News FDA Benzinga
From Benzinga
$100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags BZI/POD News Benzinga
From Benzinga
ASND Stock Earnings: Ascendis Pharma Reported Results for Q1 2024
Tickers ASND
Tags Market News NASDAQ:ASND ASND
From InvestorPlace
Looking Into Ascendis Pharma's Recent Short Interest
Tickers ASND
Tags Short Sellers Market News Short Ideas
From Benzinga
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags Market News Trading Ideas ASND
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
Tickers ASND NEWS
Tags BZI/POD News ASND
From Benzinga
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
Tickers ASND NEWS
Tags News BZI/POD Market News
From Benzinga
These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
Tickers AAPL AMZN ASND FIX
Tags AI Generated FIX Ethan Meyers
From Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $45,000 Today
Tickers ASND NEWS
Tags BZI/POD News Benzinga
From Benzinga
How Is The Market Feeling About Ascendis Pharma?
Tickers ASND
Tags Market News BZI/SHORTHIST Short Ideas
From Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $70,000 Today
Tickers ASND NEWS
Tags BZI/POD News ASND
From Benzinga
Earnings Scheduled For February 7, 2024
Tickers ACLS ADN ADNT ALCO
Tags PYPL TTE RRR
From Benzinga
Ascendis Pharma's Earnings: A Preview
Tickers ASND
Tags ASND Benzinga Market News
From Benzinga
$100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth This Much Today
Tickers ASND NEWS
Tags Market News Trading Ideas ASND
From Benzinga
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
Tickers ASND
Tags Briefs News Large Cap
From Benzinga
Analyst Expectations for Ascendis Pharma's Future
Tickers ASND
Tags BZI/AAR ASND Benzinga
From Benzinga
Recap: Ascendis Pharma Q3 Earnings
Tickers ASND
Tags BZI/Recaps Market News Earnings
From Benzinga
Preview: Ascendis Pharma's Earnings
Tickers ASND
Tags Earnings Market News BZI/EP
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags ASND BZI/AAR Benzinga
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
Tickers ASND BBIO BMRN
Tags Biotech Health Care Analyst Ratings
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags Benzinga ASND BZI/AAR
From Benzinga
Earnings Scheduled For September 5, 2023
Tickers ASAN ASND AVAV BRC
Tags PROC ASND ZS
From Benzinga
Earnings Preview For Ascendis Pharma
Tickers ASND
Tags Earnings Market News BZI/EP
From Benzinga
Analyst Expectations for Ascendis Pharma's Future
Tickers ASND
Tags Market News Analyst Ratings ASND
From Benzinga
Where Ascendis Pharma Stands With Analysts
Tickers ASND
Tags Market News Analyst Ratings Benzinga
From Benzinga
The Latest Analyst Ratings for Ascendis Pharma
Tickers ASND
Tags Analyst Ratings Market News Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Tickers APLT ASND CPHI KRBP
Tags SONX ZYXI Market News
From Benzinga
FDA Rejects Ascendis Pharma's TransCon PTH For Hypoparathyroidism
Tickers ASND
Tags why it's moving News Biotech
From Benzinga
Why Shares of Ascendis Pharma Are Climbing Monday
Tickers ASND
Tags Market News ASND Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.